Orviva

Learn · Variants · CYP2C9

rs1057910 CYP2C9

CYP2C9*3 carrier. Reduced metabolism of warfarin, NSAIDs, and oral hypoglycemics.

Curated · human-reviewed Drug response · Risk / effect allele: C · dbSNP

What is rs1057910?

rs1057910 is a single-nucleotide polymorphism (SNP) in the CYP2C9 gene (Cytochrome P450 2C9). Each person carries two copies, one from each parent, so a result is reported as a pair of letters such as AC. The table below describes what studies associate with each genotype; the association is statistical, across populations, and is not a diagnosis.

What does each rs1057910 genotype mean?

GenotypeAssociationWhat the evidence saysConfidence
AC / CAreducedCYP2C9*3 carrier. Reduced metabolism of warfarin, NSAIDs, and oral hypoglycemics.90%
CCreducedCYP2C9*3 homozygous. Significantly reduced drug metabolism.93%
AAtypicalNormal CYP2C9*3 function.92%

How common is the C allele of rs1057910?

Minor-allele frequency by population (gnomAD / 1000 Genomes):

European7.0%
East Asian4.0%
African1.0%
South Asian8.0%
Admixed American4.0%
Global5.0%

Which drugs have annotations for rs1057910?

PharmGKB clinical annotations (level 1A is the strongest evidence, 4 the weakest):

DrugAnnotation typeEvidence level
losartanEfficacy, Metabolism/PK, Toxicity, Dosage3
irbesartanEfficacy, Metabolism/PK, Toxicity, Dosage3
Antiinflammatory agentsEfficacy, Metabolism/PK3

Is rs1057910 on 23andMe and AncestryDNA chips?

Yes — it is genotyped directly on 23andMe V3, 23andMe V4, 23andMe V5, AncestryDNA V1, AncestryDNA V2. Orviva reads it from a raw-data export without imputation.

Sources

Genetic associations describe risk across populations, not a diagnosis for any one person. Most variants shift risk modestly and act alongside lifestyle, environment and other genes. Consumer DNA chips do not read every position and can be wrong at any single one. For general education only; talk to a clinician or genetic counsellor before acting on anything here, and never change a prescribed medicine without your prescriber.